论文部分内容阅读
目的观察托拉塞米注射液治疗慢性心力衰竭的疗效和安全性。方法将120例慢性心力衰竭患者随机分为治疗组60例和对照组60例。在心力衰竭常规治疗一致的情况下,治疗组应用托拉塞米注射液,对照组应用呋塞米注射液,观察疗程均为7d,观察二组的疗效和不良反应。结果治疗组有效率为90%,对照组有效率为83.3%,组间比较差异无统计学意义,但治疗组较对照组血钾变化较小(P<0.05)。结论应用托拉塞米注射液治疗慢性心力衰竭疗效肯定,安全性高于呋塞米。
Objective To observe the efficacy and safety of torsemide injection in the treatment of chronic heart failure. Methods 120 patients with chronic heart failure were randomly divided into treatment group 60 cases and control group 60 cases. In the case of conventional treatment of heart failure, the treatment group was given torsemide injection, and the control group was given furosemide injection. The treatment course was 7 days. The curative effect and adverse reactions of the two groups were observed. Results The effective rate was 90% in the treatment group and 83.3% in the control group. There was no significant difference between the two groups. However, the change of serum potassium in the treatment group was smaller than that in the control group (P <0.05). Conclusion Torasemide injection for the treatment of chronic heart failure is effective and safe than furosemide.